Wonder what this guy will say? He manages the PINK ETF. Will be interesting to watch!👀 Forbes Article: https://www.forbes.com/sites/baldwin/2025/04/23/the-health-care-stock-fund-with-an-ulterior-motive/ Michael Taylor LinkedIn profile: http://linkedin.com/in/michael-taylor-93b2454
Life has a funny way of working out, but finding certainty in the midst of hardship never seems to come with any near-term assurance. Or at least that’s been my experience. Because up until now, it’s always felt like a …
TWEEDLE TIMES—The biotech boom appears to be well underway after a three-year sabbatical. Biotech has been out of favor since its massive crash in June 2022, when investors like Cathie Wood lost as much as 90% in the sector. Wood …
Yes. An obvious need considering drone warfare advances in Ukraine, but why the video? Is the U.S. government pumping stocks now? And how many government officials bought RCAT before this video dropped? What’s next…ACHR? An Anduril feature before its upcoming …
Obviously, Reddit doesn’t tell a moderator much about demographics, but I really hope this can be a safe place for ALL investors to feel comfortable discussing investments, current events and the policies that are impacting markets. What I don’t know …
TWEEDLE TIMES—Stocks continued to roar yesterday as Nvidia became the first $4T company and President Trump blanketed planet Earth with ass-chapping letters to all the world’s leaders. The President’s literary prose came into question due to Poor Punctuation with TOO …
aTyr Pharma, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Soumit Roy from JonesTrading maintained a Buy rating on the stock and has a $22.00 price target. Soumit Roy has given his Buy rating due …
It’s all you can pick atop Monteagle Mountain. And that’s about the only real newsworthy thing that’s happening today. Nvidia being the first $4T company on the planet. Pshhh.🥱
Everyone here knows I’ve been in a particular trade and playing things aggressively for nearly two years now. But as this trade matures and we move closer to the stock’s catalyst, I’ve struggled with where to go next. Should I …
What opportunity looks like after investors lose 90% in a biotech recession (2022-2023). Were CountryDumbs greedy when the whole damn world was fearful?👍